An interventional study of Selective serotonin re-uptake inhibitor and Cognitive Behavioral Therapy in Obsessive-Compulsive Disorder, Anxiety and Depression, sponsored by Islamic Azad University, Marvdasht. Completed at 1 site in Iran, Islamic Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-12-11.
Sponsored by Islamic Azad University, Marvdasht · Not applicable, Interventional, and Treatment
Previous studies have highlighted the potential therapeutic benefits of receptive individual music therapy as an adjunct to standard care, in a variety of psychiatric ailments including mood and anxiety disorders. However, the role of music in the treatment of obsessive compulsive disorder have not been investigated to date. The present study therefore aimed to investigate the efficacy of music therapy as an adjunct to standard treatment, on obsessions in patients with treatment-naïve OCD. Moreover, given the fact that a significant proportion of patients with OCD have other comorbid mood or anxiety disorders, the question of whether therapeutic benefits of music could be expanded to also affect concurrent depressive and anxiety symptoms was explored.
8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.
This study's enrollment of 30 is below the median of 84 across 6,720 interventional studies indexed under Depression.
Browse Depression studies →This is the only study on the registry with Islamic Azad University, Marvdasht as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Selective serotonin re-uptake inhibitor plus cognitive behavioral therapy. Music therapy encompassing 12 half-hour sessions of therapist-supervised receptive music therapy scheduled over four weeks
Drug: Selective serotonin re-uptake inhibitor · Behavioral: Cognitive Behavioral Therapy · Other: Music therapy
Selective serotonin re-uptake inhibitor plus cognitive behavioral therapy.
Drug: Selective serotonin re-uptake inhibitor · Behavioral: Cognitive Behavioral Therapy
A medication of selective serotonin re-uptake inhibitor (SSRI) family, Behavioral. The type and dosage of the medication was decided by the treating psychiatrist.
Also known as: Pharmacotherapy
Cognitive Behavioral Therapy for obsessive compulsive disorder carried out by a psychologist.
Also known as: Psychotherapy
12 sessions of 30-minute individual-based receptive music therapy, supervised by the treating psychiatrist.
Also known as: Receptive music therapy
Obsession (Maudsley Obsessive-Compulsive Inventory)
Post-intervention scores on Maudsley Obsessive-Compulsive Inventory
Time frame: 1 month
Obsession subtype (Maudsley Obsessive-Compulsive Inventory sub-types)
Post-intervention scores on Maudsley Obsessive-Compulsive Inventory sub-types
Time frame: 1 month
Anxiety symptoms (Beck Anxiety Inventory)
Post-intervention scores on Beck Anxiety Inventory
Time frame: 1 month
Depressive symptoms (Beck Depression Inventory - Short Form)
Post-intervention scores on Beck Depression Inventory - Short Form
Time frame: 1 month
This study is completed, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.